FDA 483 - Medical Chemical Corporation - March 25, 2022

An FDA inspection of Medical Chemical Corporation, a medical device manufacturer in Torrance, CA, revealed significant deficiencies in their quality system. Observations included a lack of validation for a critical manufacturing line, inadequate design change procedures, and failures in complaint handling, supplier qualification, and employee training. One of the training-related observations was a repeat finding, indicating persistent issues.